ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,194 companies indexed · Last updated: today
DirectoryIndustryPharmaceutical IndustryAllschwilNeurocrine Switzerland GmbH
Neurocrine Switzerland GmbH Logo
Verified· 2 sources

Neurocrine Switzerland GmbH

Summary

About the company

Neurocrine Switzerland GmbH conducts research and development of treatments for neurological, neuroendocrine and neuropsychiatric disorders. The organisation’s portfolio includes approved medicines for conditions such as tardive dyskinesia, chorea associated with Huntington’s disease, congenital adrenal hyperplasia, endometriosis and uterine fibroids, and it maintains a pipeline with compounds in mid‑to‑late stage clinical development.

AI-generated
Offering

Products & services

Industry:Pharmaceutical Industry
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
✓ Offered5
Medicines
Medicines for neurological, psychiatric, and endocrine disorders, including approved therapies for tardive dyskinesia, Huntington’s chorea, classic congenital adrenal hyperplasia, and hyperphagia in Prader-Willi syndrome.
Research and Development of Drug Candidates
Research and development programs in neurology, endocrinology, psychiatry, and immunology, spanning preclinical to late clinical phases for small molecules, peptides, antibodies, and gene therapy.
Clinical Trials
Clinical trials in neurology, endocrinology, and psychiatry to evaluate investigational treatments, including studies in epilepsy, schizophrenia, major depressive disorder, CAH, and obesity.
Therapeutic Focus Areas
Therapeutic areas with information on diseases and treatment areas in neurology, endocrinology, and psychiatry, including TD, Huntington’s chorea, CAH, epilepsy, and Alzheimer’s-related symptoms.
Funding & Support Requests Portal
Portal for funding and support requests related to Neurocrine Biosciences, accessible via the company navigation.
Comparisons

Neurocrine Switzerland GmbH in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Neurocrine Switzerland GmbH by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Neurocrine Switzerland GmbH to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Hegenheimermattweg 167a
4123 Allschwil

At a glance

Legal form
Limited Liability Company
UID
CHE-288.406.862
Founded
2023 · 3 years
Last commercial register change
September 8, 2026
Employees
1 to 10

Knowledge

No knowledge articles yet

Once Neurocrine Switzerland GmbH has claimed this profile, we'll publish editorial articles and case studies here together.

Get started

Similar companies

MG
MiHKAL GmbH
Allschwil
AP
Actelion Pharmaceuticals Ltd
Allschwil
BP
Basilea Pharmaceutica AG, Allschwil
Allschwil
CT
CAPTOR THERAPEUTICS GmbH
Allschwil
AT
Alloy Therapeutics (Switzerland) AG
Allschwil
IP
Idorsia Pharmaceuticals Ltd
Allschwil
TP
T3 Pharmaceuticals AG
Allschwil
PT
Palto Therapeutics AG
Allschwil